Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT05111561
What this trial is testing

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04317105
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Looking for participantsNCT06737731
What this trial is testing

A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT07541001
What this trial is testing

PRL3-Zumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Intra-IMMUSG Pte Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT07112222
What this trial is testing

LM-350 in Subjects With Advanced Solid Tumours

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 80
Early research (Phase 1)Active Not RecruitingNCT05495295
What this trial is testing

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

Who this might be right for
Malignant TumorAdvanced Solid TumorGlioblastoma Multiforme+1 more
Phost'In Therapeutics 149
Early research (Phase 1)Not Yet RecruitingNCT07615894
What this trial is testing

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Who this might be right for
Advanced Solid TumorsMalignant Pleural EffusionsMalignant Ascites
WestVac Biopharma Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194
What this trial is testing

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Who this might be right for
Locally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more
National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439266
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT02518958
What this trial is testing

A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab

Who this might be right for
Malignant Solid TumorLymphoma
EpicentRx, Inc. 12
Not applicableStudy completedNCT02111889
What this trial is testing

Tumor Kinase Inhibitor Concentrations Measured by PET

Who this might be right for
Disseminated Malignant Neoplasm
Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Study completedNCT00576654
What this trial is testing

Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmTriple-Negative Breast Carcinoma+1 more
National Cancer Institute (NCI) 73
Early research (Phase 1)Active Not RecruitingNCT01480154
What this trial is testing

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmStage III Cutaneous Melanoma AJCC v7Stage III Prostate Cancer AJCC v7+7 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Early research (Phase 1)Ended earlyNCT00195325
What this trial is testing

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

Who this might be right for
TumorsNeoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 45
Early research (Phase 1)Study completedNCT05082610
What this trial is testing

HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

Who this might be right for
CancerTumor, SolidNonsmall Cell Lung Cancer+4 more
Hummingbird Bioscience 48
Testing effectiveness (Phase 2)Study completedNCT01792310
What this trial is testing

A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours

Who this might be right for
GliomaOther Solid Tumours
Laminar Pharmaceuticals 54
Early research (Phase 1)UnknownNCT05171790
What this trial is testing

Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 419
Next Page